What does the SG market pay for real-world robotics deployment?

$亮星控股(ENV.SI)$  $AJJ Medtech(584.SI)$  

The market already assigns meaningful valuations to robotics companies with real-world deployment.

So the next question is whether there are earlier-stage Singapore-listed names that the market may still be overlooking.

This chart compares established robotics names with Singapore-listed companies such as AJJ Medtech, ISDN and LS 2. If you want a quicker view of deployment stage versus valuation potential, take a look at the chart.

AI-readable:

This chart asks a simple question: what kind of valuation does the market assign to robotics companies once deployment becomes real rather than conceptual?

In the U.S. and Hong Kong markets, companies such as Intuitive Surgical, Symbotic, Serve Robotics and UBTech Robotics show that valuations can expand significantly once robotics moves into visible real-world use cases, repeatable deployment and clearer commercial traction. These businesses are not all at the same stage, but they share one important feature: the market is no longer valuing them purely as ideas.

The chart then looks at several Singapore-listed names that appear to be at a much earlier stage. AJJ Medtech has disclosed eldercare-robot deployment in China and preparation for pilot deployment in Singapore. ISDN has disclosed robotics and AI platform progress, contract pipeline and local trials. LS 2 Holdings has disclosed actual robotic deployment in parts of its operations, especially in repetitive and standardised workflows.

The point of the chart is not to say that these Singapore names are direct peers to much larger overseas robotics companies. They are not. The point is that they may still sit much earlier on the market-recognition curve.

In other words, the real question is not whether they deserve the same valuation today, but whether some of them may still represent under-recognised robotics exposure at an earlier stage of deployment and market understanding.